Clinical Trial Update: A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating loading doses of intravenous ibandronate (Bondronat) in patients with breast cancer and malignant bone disease; the trial status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer

Drugs mentioned

• Bondronat (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Pain; Bone Neoplasms; Neoplasm Metastasis | Phase 2 | Status: COMPLETED